I AM HERE: An Intimate Portrait Sequence launches as we speak
IRVINE, California, Oct. 1, 2020 /PRNewswire/ — In celebration of Breast Most cancers Consciousness Month, Agendia, Inc., a world chief in precision oncology for breast most cancers, is proud to current the I AM HERE marketing campaign, a group of illustrations and tales that seize the extremely private journey of a breast most cancers analysis and therapy. I AM HERE is a portrait sequence by famend visible artist Andrea Caceres that illustrates the essence of those that have been touched by breast most cancers, showcasing a selected second that exemplifies the explanation why they’re right here.
“We all know that one month a yr isn’t sufficient to acknowledge the vulnerability, grit, grace, and resilience exhibited by breast most cancers sufferers, survivors, and their households and care groups each single day,” mentioned Mark Straley, Chief Govt Officer of Agendia. “We’re honored to associate with Andrea and might’t wait to see her interpretation of the unbelievable experiences and inspirations the individuals in our neighborhood must share.”
Agendia is embarking on a months-long look past the mammogram to showcase the power, complexity, and neighborhood behind every analysis. Breast most cancers sufferers and the complete range of the breast most cancers care neighborhood are invited to share their tales by way of a photograph that illustrates the explanation they’re right here as we speak, with a brief rationalization to additional illuminate the significance of their chosen second in time.
“Since my very own breast most cancers analysis a number of years in the past, which adopted my mom’s and sister’s personal diagnoses, I’ve been so blessed to turn out to be a breast most cancers advocate,” mentioned LaTonya Davis, a breast most cancers survivor, host of the upcoming podcast The Breast Discuss Ever, and one of many first to have her story illustrated by Andrea for I AM HERE. “I hope to make sure different girls know my story and might use it to their benefit. If my race, as I name it, can provide only one different particular person the knowledge they should ask the proper questions, that energy that’s carried on by way of them will proceed to make waves far past my very own journey.”
A most cancers journey begins at analysis and turns into a relentless companion, redefining the previous, current, and way forward for the affected person. On this sequence, a platform is offered to honor the complexity, the inspiring “whys,” and the each day items, trials, and victories that sufferers, well being care groups, and households expertise as they stroll ahead collectively.
“I like to illustrate girls and share tales about their tradition, their historical past, and who they are surely,” mentioned artist Andrea Caceres. “To me the ladies on this sequence symbolize greater than a illness – they’re moms, daughters, sisters, individuals with ardour, and a zest for all times. ‘I AM HERE’, to me, displays how multi-faceted and resilient these girls are, I really feel very honored to symbolize them by way of my artwork.”
The ever-changing assortment of tales and illustrations will be discovered at www.agendia.com/i-am-here. Agendia encourages all who’ve been touched by breast most cancers to submit their tales to the portal, and to comply with alongside on social media on the hashtag #IAMHERE.
Agendia is deeply dedicated to the complete breadth of the breast most cancers neighborhood, and goals to arm sufferers and their help programs with the robust science they should make knowledgeable, right-sized therapy selections.
Agendia is a precision oncology firm headquartered in Irvine, California, dedicated to bringing early stage breast most cancers sufferers and their physicians the knowledge they should make the simplest therapy selections. The corporate presently gives two commercially-available genomic profiling assessments, supported by scientific and actual world proof. MammaPrint®, the 70-gene breast most cancers recurrence assay, and BluePrint®, the 80-gene molecular subtyping assay, present a complete genomic profile and the information physicians must make extra knowledgeable selections within the pre- and post-operative therapy settings. By creating evidence-based novel genomic assessments and conducting groundbreaking analysis whereas constructing an arsenal of knowledge that may assist deal with most cancers, Agendia goals to enhance affected person outcomes and help the evolving scientific wants of breast most cancers sufferers and their physicians each step of the best way, from preliminary analysis to cancer-free.
Brand – https://mma.prnewswire.com/media/1002892/Agendia_Logo.jpg